HomeAbout usHospitalsSearchLogin
Your medical data, safe and secure.
Name
AC3056
Description
AC3056 is a non-peptide antioxidant that acts as an inhibitor of vascular cell adhesion molecule expression originally developed by Aventis Pharmaceuticals. It as since been acquired by Amylin Pharmaceuticals and has completed phase I trials.
No brand information found.
